Analyst Price Targets — STE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 24, 2024 3:23 am | Jason Bednar | Piper Sandler | $260.00 | $221.15 | StreetInsider | Piper Sandler Upgrades STERIS (STE) to Overweight |
| September 3, 2024 6:28 am | Brett Fishbin | KeyBanc | $265.00 | $241.10 | TheFly | Steris price target raised to $265 from $255 at KeyBanc |
| May 10, 2024 8:20 am | Jason Bednar | Piper Sandler | $225.00 | $225.95 | StreetInsider | STERIS (STE) PT Raised to $225 at Piper Sandler |
| April 4, 2024 4:23 am | Mike Polark | Wolfe Research | $245.00 | $216.65 | StreetInsider | STERIS (STE) PT Raised to $245 at Wolfe Research |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for STE

Dana Investment Advisors Inc. increased its position in STERIS plc (NYSE: STE) by 688.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,712 shares of the medical equipment provider's stock after purchasing an additional 39,043 shares during the period. Dana Investment Advisors Inc.'s holdings

STERIS plc (NYSE: STE - Get Free Report) has received an average rating of "Moderate Buy" from the eight brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price target among brokerages

STERIS plc (NYSE: STE - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 1,560,494 shares, an increase of 22.7% from the January 15th total of 1,271,747 shares. Currently, 1.6% of the company's stock are sold short. Based

STERIS (NYSE: STE - Get Free Report) and QHSLab (OTCMKTS:USAQ - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Valuation and Earnings This table compares STERIS and QHSLab"s gross

Explore Steris' (STE) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
